테바인 시장 : 시장 점유율과 순위, 전체 판매 및 수요 예측(2025-2031년)

The global market for Thebaine was estimated to be worth US$ 59.6 million in 2024 and is forecast to a readjusted size of US$ 58.4 million by 2031 with a CAGR of -0.3% during the forecast period 2025-2031.

This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Thebaine cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.

Thebaine, also known as paramorphine, is a white, crystalline, slightly water-soluble (in pure form after a synthesis), poisonous alkaloid. Thebaine is not used therapeutically, but as the main alkaloid extracted from papaver bracteatum (Iranian poppy), it can be converted industrially into a variety of compounds including oxycodone, oxymorphone, nalbuphine, naloxone, naltrexone, buprenorphine and etorphine.

The thebaine market plays a vital role within the global pharmaceutical and opioid supply chain. Thebaine, a naturally occurring alkaloid found in opium poppy, is primarily used as a precursor in the synthesis of various semi-synthetic opioids such as oxycodone, buprenorphine, and naloxone. Unlike morphine or codeine, thebaine itself is not used therapeutically due to its stimulatory and potentially toxic effects at therapeutic doses. Instead, its value lies in its chemical structure, which lends itself well to modification in pharmaceutical manufacturing. Demand for thebaine is closely tied to the needs of the pharmaceutical industry, particularly in pain management, addiction treatment, and anesthesia.

The market is influenced by a complex interplay of regulatory frameworks, geopolitical dynamics, and evolving public health priorities. Stringent controls are in place due to thebaine's association with controlled substances, which affects both production and trade. Additionally, shifting attitudes toward opioid use-spurred by the opioid crisis in several countries-are prompting changes in prescribing practices and encouraging research into alternative therapies. These factors, along with innovation in synthetic biology and poppy cultivation, continue to shape the trajectory of the thebaine market, making it a strategically significant but highly regulated segment of the global pharmaceutical industry.

This report aims to provide a comprehensive presentation of the global market for Thebaine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Thebaine by region & country, by Type, and by Application.

The Thebaine market size, estimations, and forecasts are provided in terms of sales volume (MT) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Thebaine.

Market Segmentation

By Company

• Sun Pharmaceutical
• Tasmanian Alkaloids
• Alcaliber
• TPI
• Cepia-Sanofi
• Taj Pharmaceuticals
• Gansu Alkaloids

Segment by Type

• Extraction from Poppy Straw
• Extraction from Opium

Segment by Application

• Oxycodone
• Hydrocodone
• Buprenorphine
• Others

By Region

• North America
  • United States
  • Canada
• Asia-Pacific
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Australia
  • Rest of Asia-Pacific
• Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Netherlands
  • Nordic Countries
  • Rest of Europe
• Latin America
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 2: Detailed analysis of Thebaine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Sales, revenue of Thebaine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 6: Sales, revenue of Thebaine in country level. It provides sigmate data by Type, and by Application for each country/region.

Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 9: Conclusion.

Table of Contents

1 Market Overview

• 1.1 Thebaine Product Introduction
• 1.2 Global Thebaine Market Size Forecast
  • 1.2.1 Global Thebaine Sales Value (2020-2031)
  • 1.2.2 Global Thebaine Sales Volume (2020-2031)
  • 1.2.3 Global Thebaine Sales Price (2020-2031)
• 1.3 Thebaine Market Trends & Drivers
  • 1.3.1 Thebaine Industry Trends
  • 1.3.2 Thebaine Market Drivers & Opportunity
  • 1.3.3 Thebaine Market Challenges
  • 1.3.4 Thebaine Market Restraints
• 1.4 Assumptions and Limitations
• 1.5 Study Objectives
• 1.6 Years Considered

2 Competitive Analysis by Company

• 2.1 Global Thebaine Players Revenue Ranking (2024)
• 2.2 Global Thebaine Revenue by Company (2020-2025)
• 2.3 Global Thebaine Players Sales Volume Ranking (2024)
• 2.4 Global Thebaine Sales Volume by Company Players (2020-2025)
• 2.5 Global Thebaine Average Price by Company (2020-2025)
• 2.6 Key Manufacturers Thebaine Manufacturing Base and Headquarters
• 2.7 Key Manufacturers Thebaine Product Offered
• 2.8 Key Manufacturers Time to Begin Mass Production of Thebaine
• 2.9 Thebaine Market Competitive Analysis
  • 2.9.1 Thebaine Market Concentration Rate (2020-2025)
  • 2.9.2 Global 5 and 10 Largest Manufacturers by Thebaine Revenue in 2024
  • 2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Thebaine as of 2024)
• 2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

• 3.1 Introduction by Type
  • 3.1.1 Extraction from Poppy Straw
  • 3.1.2 Extraction from Opium
• 3.2 Global Thebaine Sales Value by Type
  • 3.2.1 Global Thebaine Sales Value by Type (2020 VS 2024 VS 2031)
  • 3.2.2 Global Thebaine Sales Value, by Type (2020-2031)
  • 3.2.3 Global Thebaine Sales Value, by Type (%) (2020-2031)
• 3.3 Global Thebaine Sales Volume by Type
  • 3.3.1 Global Thebaine Sales Volume by Type (2020 VS 2024 VS 2031)
  • 3.3.2 Global Thebaine Sales Volume, by Type (2020-2031)
  • 3.3.3 Global Thebaine Sales Volume, by Type (%) (2020-2031)
• 3.4 Global Thebaine Average Price by Type (2020-2031)

4 Segmentation by Application

• 4.1 Introduction by Application
  • 4.1.1 Oxycodone
  • 4.1.2 Hydrocodone
  • 4.1.3 Buprenorphine
  • 4.1.4 Others
• 4.2 Global Thebaine Sales Value by Application
  • 4.2.1 Global Thebaine Sales Value by Application (2020 VS 2024 VS 2031)
  • 4.2.2 Global Thebaine Sales Value, by Application (2020-2031)
  • 4.2.3 Global Thebaine Sales Value, by Application (%) (2020-2031)
• 4.3 Global Thebaine Sales Volume by Application
  • 4.3.1 Global Thebaine Sales Volume by Application (2020 VS 2024 VS 2031)
  • 4.3.2 Global Thebaine Sales Volume, by Application (2020-2031)
  • 4.3.3 Global Thebaine Sales Volume, by Application (%) (2020-2031)
• 4.4 Global Thebaine Average Price by Application (2020-2031)

5 Segmentation by Region

• 5.1 Global Thebaine Sales Value by Region
  • 5.1.1 Global Thebaine Sales Value by Region: 2020 VS 2024 VS 2031
  • 5.1.2 Global Thebaine Sales Value by Region (2020-2025)
  • 5.1.3 Global Thebaine Sales Value by Region (2026-2031)
  • 5.1.4 Global Thebaine Sales Value by Region (%), (2020-2031)
• 5.2 Global Thebaine Sales Volume by Region
  • 5.2.1 Global Thebaine Sales Volume by Region: 2020 VS 2024 VS 2031
  • 5.2.2 Global Thebaine Sales Volume by Region (2020-2025)
  • 5.2.3 Global Thebaine Sales Volume by Region (2026-2031)
  • 5.2.4 Global Thebaine Sales Volume by Region (%), (2020-2031)
• 5.3 Global Thebaine Average Price by Region (2020-2031)
• 5.4 North America
  • 5.4.1 North America Thebaine Sales Value, 2020-2031
  • 5.4.2 North America Thebaine Sales Value by Country (%), 2024 VS 2031
• 5.5 Europe
  • 5.5.1 Europe Thebaine Sales Value, 2020-2031
  • 5.5.2 Europe Thebaine Sales Value by Country (%), 2024 VS 2031
• 5.6 Asia Pacific
  • 5.6.1 Asia Pacific Thebaine Sales Value, 2020-2031
  • 5.6.2 Asia Pacific Thebaine Sales Value by Region (%), 2024 VS 2031
• 5.7 South America
  • 5.7.1 South America Thebaine Sales Value, 2020-2031
  • 5.7.2 South America Thebaine Sales Value by Country (%), 2024 VS 2031
• 5.8 Middle East & Africa
  • 5.8.1 Middle East & Africa Thebaine Sales Value, 2020-2031
  • 5.8.2 Middle East & Africa Thebaine Sales Value by Country (%), 2024 VS 2031

6 Segmentation by Key Countries/Regions

• 6.1 Key Countries/Regions Thebaine Sales Value Growth Trends, 2020 VS 2024 VS 2031
• 6.2 Key Countries/Regions Thebaine Sales Value and Sales Volume
  • 6.2.1 Key Countries/Regions Thebaine Sales Value, 2020-2031
  • 6.2.2 Key Countries/Regions Thebaine Sales Volume, 2020-2031
• 6.3 United States
  • 6.3.1 United States Thebaine Sales Value, 2020-2031
  • 6.3.2 United States Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.3.3 United States Thebaine Sales Value by Application, 2024 VS 2031
• 6.4 Europe
  • 6.4.1 Europe Thebaine Sales Value, 2020-2031
  • 6.4.2 Europe Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.4.3 Europe Thebaine Sales Value by Application, 2024 VS 2031
• 6.5 China
  • 6.5.1 China Thebaine Sales Value, 2020-2031
  • 6.5.2 China Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.5.3 China Thebaine Sales Value by Application, 2024 VS 2031
• 6.6 Japan
  • 6.6.1 Japan Thebaine Sales Value, 2020-2031
  • 6.6.2 Japan Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.6.3 Japan Thebaine Sales Value by Application, 2024 VS 2031
• 6.7 South Korea
  • 6.7.1 South Korea Thebaine Sales Value, 2020-2031
  • 6.7.2 South Korea Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.7.3 South Korea Thebaine Sales Value by Application, 2024 VS 2031
• 6.8 Southeast Asia
  • 6.8.1 Southeast Asia Thebaine Sales Value, 2020-2031
  • 6.8.2 Southeast Asia Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.8.3 Southeast Asia Thebaine Sales Value by Application, 2024 VS 2031
• 6.9 India
  • 6.9.1 India Thebaine Sales Value, 2020-2031
  • 6.9.2 India Thebaine Sales Value by Type (%), 2024 VS 2031
  • 6.9.3 India Thebaine Sales Value by Application, 2024 VS 2031

7 Company Profiles

• 7.1 Sun Pharmaceutical
  • 7.1.1 Sun Pharmaceutical Company Information
  • 7.1.2 Sun Pharmaceutical Introduction and Business Overview
  • 7.1.3 Sun Pharmaceutical Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.1.4 Sun Pharmaceutical Thebaine Product Offerings
  • 7.1.5 Sun Pharmaceutical Recent Development
• 7.2 Tasmanian Alkaloids
  • 7.2.1 Tasmanian Alkaloids Company Information
  • 7.2.2 Tasmanian Alkaloids Introduction and Business Overview
  • 7.2.3 Tasmanian Alkaloids Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.2.4 Tasmanian Alkaloids Thebaine Product Offerings
  • 7.2.5 Tasmanian Alkaloids Recent Development
• 7.3 Alcaliber
  • 7.3.1 Alcaliber Company Information
  • 7.3.2 Alcaliber Introduction and Business Overview
  • 7.3.3 Alcaliber Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.3.4 Alcaliber Thebaine Product Offerings
  • 7.3.5 Alcaliber Recent Development
• 7.4 TPI
  • 7.4.1 TPI Company Information
  • 7.4.2 TPI Introduction and Business Overview
  • 7.4.3 TPI Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.4.4 TPI Thebaine Product Offerings
  • 7.4.5 TPI Recent Development
• 7.5 Cepia-Sanofi
  • 7.5.1 Cepia-Sanofi Company Information
  • 7.5.2 Cepia-Sanofi Introduction and Business Overview
  • 7.5.3 Cepia-Sanofi Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.5.4 Cepia-Sanofi Thebaine Product Offerings
  • 7.5.5 Cepia-Sanofi Recent Development
• 7.6 Taj Pharmaceuticals
  • 7.6.1 Taj Pharmaceuticals Company Information
  • 7.6.2 Taj Pharmaceuticals Introduction and Business Overview
  • 7.6.3 Taj Pharmaceuticals Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.6.4 Taj Pharmaceuticals Thebaine Product Offerings
  • 7.6.5 Taj Pharmaceuticals Recent Development
• 7.7 Gansu Alkaloids
  • 7.7.1 Gansu Alkaloids Company Information
  • 7.7.2 Gansu Alkaloids Introduction and Business Overview
  • 7.7.3 Gansu Alkaloids Thebaine Sales, Revenue, Price and Gross Margin (2020-2025)
  • 7.7.4 Gansu Alkaloids Thebaine Product Offerings
  • 7.7.5 Gansu Alkaloids Recent Development

8 Industry Chain Analysis

• 8.1 Thebaine Industrial Chain
• 8.2 Thebaine Upstream Analysis
  • 8.2.1 Key Raw Materials
  • 8.2.2 Raw Materials Key Suppliers
  • 8.2.3 Manufacturing Cost Structure
• 8.3 Midstream Analysis
• 8.4 Downstream Analysis (Customers Analysis)
• 8.5 Sales Model and Sales Channels
  • 8.5.1 Thebaine Sales Model
  • 8.5.2 Sales Channel
  • 8.5.3 Thebaine Distributors

9 Research Findings and Conclusion

10 Appendix

• 10.1 Research Methodology
  • 10.1.1 Methodology/Research Approach
    • 10.1.1.1 Research Programs/Design
    • 10.1.1.2 Market Size Estimation
    • 10.1.1.3 Market Breakdown and Data Triangulation
  • 10.1.2 Data Source
    • 10.1.2.1 Secondary Sources
    • 10.1.2.2 Primary Sources
• 10.2 Author Details
• 10.3 Disclaimer